IOSP Innospec Inc

Price (delayed)

$86.16

Market cap

$2.12B

P/E Ratio

26.11

Dividend/share

$1.09

EPS

$3.3

Enterprise value

$2.07B

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, ...

Highlights
The stock's price to earnings (P/E) is 63% less than its last 4 quarters average of 70.0 and 19% less than its 5-year quarterly average of 32.2
Innospec's net income has increased by 49% YoY
IOSP's gross profit is up by 15% since the previous quarter but it is down by 8% year-on-year
Innospec's revenue has increased by 9% QoQ but it has decreased by 8% YoY

Key stats

What are the main financial stats of IOSP
Market
Shares outstanding
24.64M
Market cap
$2.12B
Enterprise value
$2.07B
Valuations
Price to earnings (P/E)
26.11
Price to book (P/B)
2.18
Price to sales (P/S)
1.67
EV/EBIT
16.99
EV/EBITDA
12.59
EV/Sales
1.63
Earnings
Revenue
$1.27B
EBIT
$121.6M
EBITDA
$164M
Free cash flow
$101M
Per share
EPS
$3.3
Free cash flow per share
$4.1
Book value per share
$39.56
Revenue per share
$51.57
TBVPS
$41.71
Balance sheet
Total assets
$1.46B
Total liabilities
$487.6M
Debt
$36.7M
Equity
$973.6M
Working capital
$352.1M
Liquidity
Debt to equity
0.04
Current ratio
2.21
Quick ratio
1.29
Net debt/EBITDA
-0.35
Margins
EBITDA margin
12.9%
Gross margin
29.8%
Net margin
6.4%
Operating margin
8.8%
Efficiency
Return on assets
5.8%
Return on equity
8.5%
Return on invested capital
18.9%
Return on capital employed
10.4%
Return on sales
9.6%
Dividend
Dividend yield
1.27%
DPS
$1.09
Payout ratio
33%

IOSP stock price

How has the Innospec stock price performed over time
Intraday
-0.74%
1 week
-5.29%
1 month
-7.64%
1 year
27.47%
YTD
-5.04%
QTD
-4.91%

Financial performance

How have Innospec's revenue and profit performed over time
Revenue
$1.27B
Gross profit
$378.8M
Operating income
$111.4M
Net income
$81.1M
Gross margin
29.8%
Net margin
6.4%
The operating margin has surged by 76% year-on-year
The net margin has surged by 60% year-on-year
The company's operating income has surged by 60% YoY
Innospec's net income has increased by 49% YoY

Growth

What is Innospec's growth rate over time

Valuation

What is Innospec stock price valuation
P/E
26.11
P/B
2.18
P/S
1.67
EV/EBIT
16.99
EV/EBITDA
12.59
EV/Sales
1.63
The stock's price to earnings (P/E) is 63% less than its last 4 quarters average of 70.0 and 19% less than its 5-year quarterly average of 32.2
The company's EPS rose by 48% YoY
The equity is up by 8% YoY
The price to sales (P/S) is 11% higher than the 5-year quarterly average of 1.5 but 7% lower than the last 4 quarters average of 1.8
Innospec's revenue has increased by 9% QoQ but it has decreased by 8% YoY

Efficiency

How efficient is Innospec business performance
IOSP's return on invested capital has surged by 83% year-on-year
The company's return on sales has surged by 78% YoY
IOSP's ROA has soared by 53% year-on-year
Innospec's ROE has increased by 42% YoY

Dividends

What is IOSP's dividend history
DPS
$1.09
Dividend yield
1.27%
Payout ratio
33%
Recent dividends

Financial health

How did Innospec financials performed over time
Innospec's total assets is 200% more than its total liabilities
The total liabilities has increased by 11% year-on-year and by 4.4% since the previous quarter
The current ratio has contracted by 9% YoY
The debt is 96% smaller than the equity
Innospec's debt to equity has plunged by 50% YoY
The debt has declined by 47% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.